Ledyard National Bank Tekla Life Sciences Investors Transaction History

Ledyard National Bank

$1.06 Billion
Q4 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 Apr 12, 2019	SELL	$15.5 - $17.9 $61,783 - $71,349	-3,986 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$18.89 - $20.49 $1,530 - $1,659	81 Added 2.07%	3,986 $81,000
Q2 2018 Jul 11, 2018	BUY	$18.13 - $19.4 $1,450 - $1,552	80 Added 2.09%	3,905 $73,000
Q1 2018 Apr 16, 2018	BUY	$18.92 - $21.52 $72,369 - $82,314	3,825 New	3,825 $74,000

Others Institutions Holding HQL

# of Institutions

77

Shares Held

9.86M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$48.1 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.9 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.87 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.57 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.85 Million
0.14% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.